|
JP2001026506A
(ja)
*
|
1999-04-28 |
2001-01-30 |
Takeda Chem Ind Ltd |
スルホンアミド誘導体
|
|
US6586617B1
(en)
|
1999-04-28 |
2003-07-01 |
Sumitomo Chemical Takeda Agro Company, Limited |
Sulfonamide derivatives
|
|
US6503949B1
(en)
*
|
1999-05-17 |
2003-01-07 |
Noro Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
EP1335901B1
(en)
|
2000-10-17 |
2010-04-14 |
Merck Serono SA |
Pharmaceutically active sulfanilide derivatives
|
|
HUP0303857A3
(en)
|
2000-12-13 |
2007-07-30 |
Wyeth Corp |
Heterocyclic sulifonamide inhibitors of beta amyloid production
|
|
US6657070B2
(en)
|
2000-12-13 |
2003-12-02 |
Wyeth |
Production of chirally pure α-amino acids and N-sulfonyl α-amino acids
|
|
GB0108592D0
(en)
|
2001-04-05 |
2001-05-23 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GB0108591D0
(en)
|
2001-04-05 |
2001-05-23 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US20040192673A1
(en)
*
|
2001-05-05 |
2004-09-30 |
Pascale Gaillard |
N-aroyl cyclic amine derivatives as orexin receptor antagonists
|
|
GB0115862D0
(en)
*
|
2001-06-28 |
2001-08-22 |
Smithkline Beecham Plc |
Compounds
|
|
JP2005504042A
(ja)
|
2001-08-03 |
2005-02-10 |
シェーリング コーポレイション |
γセクレターゼインヒビターのようなスルホンアミド誘導体
|
|
WO2003014075A2
(en)
*
|
2001-08-03 |
2003-02-20 |
Schering Corporation |
Novel gamma secretase inhibitors
|
|
GB0120347D0
(en)
|
2001-08-21 |
2001-10-17 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
PE20030701A1
(es)
|
2001-12-20 |
2003-08-21 |
Schering Corp |
Compuestos para el tratamiento de trastornos inflamatorios
|
|
CN1289469C
(zh)
|
2001-12-20 |
2006-12-13 |
布里斯托尔-迈尔斯斯奎布公司 |
α－(N－磺酰氨基)乙酰胺衍生物作为β－淀粉样蛋白抑制剂
|
|
CN100562516C
(zh)
|
2001-12-27 |
2009-11-25 |
第一制药株式会社 |
β-淀粉样蛋白产生和分泌的抑制剂
|
|
DE10201392A1
(de)
*
|
2002-01-16 |
2003-07-31 |
Bayer Ag |
Phenylsulfoxide und-sulfone
|
|
JP4530849B2
(ja)
*
|
2002-06-11 |
2010-08-25 |
ワイス・エルエルシー |
βアミロイド産生の置換フェニルスルホンアミド阻害剤
|
|
US6989399B2
(en)
|
2002-08-01 |
2006-01-24 |
Bristol-Myers Squibb Company |
Antiamyloid phenylsulfonamides: N-alkanol derivatives
|
|
GB0223038D0
(en)
|
2002-10-04 |
2002-11-13 |
Merck Sharp & Dohme |
Therapeutic compounds
|
|
GB0223040D0
(en)
|
2002-10-04 |
2002-11-13 |
Merck Sharp & Dohme |
Therapeutic compounds
|
|
GB0223039D0
(en)
|
2002-10-04 |
2002-11-13 |
Merck Sharp & Dohme |
Therapeutic compounds
|
|
US7279578B2
(en)
|
2002-10-11 |
2007-10-09 |
Actelion Pharmaceuticals Ltd. |
Sulfonylamino-acetic acid derivatives
|
|
US7521481B2
(en)
|
2003-02-27 |
2009-04-21 |
Mclaurin Joanne |
Methods of preventing, treating and diagnosing disorders of protein aggregation
|
|
WO2004080952A1
(de)
*
|
2003-03-10 |
2004-09-23 |
Bayer Healthcare Ag |
Phenylsulfonamid-derivate zur behandlung der alzheimerschen krankheit
|
|
BRPI0408962A
(pt)
|
2003-03-31 |
2006-04-04 |
Wyeth Corp |
inibidores sulfonamidas heterocìclicos contendo flúor- e trifluoroalquila da produção de beta amilóide e seus derivados
|
|
BRPI0409447A
(pt)
*
|
2003-04-14 |
2006-04-18 |
Inst For Pharm Discovery Inc |
ácidos fenilalcanóicos substituìdos
|
|
DE602004015110D1
(de)
|
2003-05-13 |
2008-08-28 |
Schering Corp |
Verbrückte n-arylsulfonylpiperidine als gamma-sekretaseinhibitoren
|
|
EP1638951B1
(en)
|
2003-05-16 |
2008-02-13 |
MERCK SHARP & DOHME LTD. |
Cyclohexyl sulphones as gamma-secretase inhibitors
|
|
JP5146714B2
(ja)
*
|
2003-06-23 |
2013-02-20 |
ビーエイチアイ リミテッド パートナーシップ |
アミロイド関連疾患を治療するための方法および組成物
|
|
CA2526487A1
(en)
|
2003-06-30 |
2005-01-06 |
Daiichi Pharmaceutical Co., Ltd. |
Heterocyclic methyl sulfone derivative
|
|
MXPA06001558A
(es)
|
2003-08-08 |
2006-05-15 |
Schering Corp |
Inhibidores de amina ciclica bace-1 que poseen un sustituyente heterociclico.
|
|
ES2323068T3
(es)
|
2003-08-08 |
2009-07-06 |
Schering Corporation |
Inhibidores de bace-1 de aminas ciclicas con un sustituyente de benzamida.
|
|
GB0323258D0
(en)
|
2003-10-04 |
2003-11-05 |
Merck Sharp & Dohme |
Therapeutic compounds
|
|
RU2364587C2
(ru)
*
|
2003-10-29 |
2009-08-20 |
Элан Фармасьютикалз, Инк. |
N-замещенные бензолсульфонамиды
|
|
ES2330451T3
(es)
|
2004-01-16 |
2009-12-10 |
Wyeth |
Inhibidores a base de sulfonamidas heterociclicas de la produccion de beta-amiloides que contienen un azol.
|
|
US8193389B2
(en)
|
2004-03-11 |
2012-06-05 |
Elan Pharmaceuticals, Inc. |
N-substituted benzene sulfonamides
|
|
AU2005230902A1
(en)
|
2004-03-31 |
2005-10-20 |
Janssen Pharmaceutica, N.V. |
Non-imidazole heterocyclic compounds as histamine H3-receptor ligands
|
|
MY149038A
(en)
|
2004-05-26 |
2013-07-15 |
Eisai R&D Man Co Ltd |
Cinnamide compound
|
|
PE20060481A1
(es)
|
2004-06-30 |
2006-06-19 |
Schering Corp |
N-arilsulfonilaminas heterociclicas sustituidas como inhibidores de gamma-secretasas
|
|
EP1781625B1
(en)
|
2004-07-22 |
2010-12-15 |
Schering Corporation |
Substituted amide beta secretase inhibitors
|
|
CA2580119A1
(en)
|
2004-10-26 |
2006-05-04 |
Eisai R & D Management Co., Ltd. |
Amorphous object of cinnamide compound
|
|
TW200630327A
(en)
*
|
2004-10-28 |
2006-09-01 |
Inst For Pharm Discovery Inc |
Substituted phenylalkanoic acids
|
|
CA2595173A1
(en)
|
2005-01-18 |
2006-07-27 |
Elan Pharmaceuticals, Inc. |
N-substituted heterocyclic sulfonamides
|
|
WO2006080043A2
(en)
*
|
2005-01-27 |
2006-08-03 |
Alma Mater Studiorum- Universita' Di Bologna |
Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation
|
|
US8114886B2
(en)
*
|
2005-04-08 |
2012-02-14 |
Daiichi Sankyo Company, Limited |
Pyridylmethylsulfone derivative
|
|
RU2381225C1
(ru)
|
2005-11-24 |
2010-02-10 |
Эйсай Ар Энд Ди Менеджмент Ко., Лтд. |
Производное циннамида типа морфолина
|
|
TWI370130B
(en)
|
2005-11-24 |
2012-08-11 |
Eisai R&D Man Co Ltd |
Two cyclic cinnamide compound
|
|
KR20080095885A
(ko)
|
2006-01-20 |
2008-10-29 |
쉐링 코포레이션 |
벤젠설포닐-크로만, 티오크로만, 테트라하이드로나프탈렌 및 관련된 감마 세크라타제 억제제
|
|
WO2007092861A2
(en)
*
|
2006-02-06 |
2007-08-16 |
Elan Pharmaceuticals, Inc. |
Inhibitors specific of presenilin-1 and their uses
|
|
US9567396B2
(en)
|
2006-03-07 |
2017-02-14 |
Evonik Degussa Gmbh |
Notch inhibition in the prevention of vein graft failure
|
|
WO2007103114A2
(en)
*
|
2006-03-07 |
2007-09-13 |
The Brigham & Women's Hospital, Inc. |
Notch inhibition in the treatment or prevention of atherosclerosis
|
|
TWI378091B
(en)
|
2006-03-09 |
2012-12-01 |
Eisai R&D Man Co Ltd |
Multi-cyclic cinnamide derivatives
|
|
CA2646917A1
(en)
|
2006-04-11 |
2007-10-18 |
Actelion Pharmaceuticals Ltd |
Novel sulfonamide compounds
|
|
EA015555B1
(ru)
|
2006-05-30 |
2011-08-30 |
Янссен Фармацевтика Н.В. |
Замещенные пиридиламидные соединения в качестве модуляторов гистаминового h-рецептора
|
|
AR062095A1
(es)
|
2006-07-28 |
2008-10-15 |
Eisai R&D Man Co Ltd |
Profarmaco de compuesto cinamida
|
|
TW200817319A
(en)
|
2006-08-10 |
2008-04-16 |
Astellas Pharma Inc |
Sulfonamide compound or salt thereof
|
|
WO2008061247A2
(en)
*
|
2006-11-16 |
2008-05-22 |
The Regent Of The University Of California |
Benzenesulfonanilide compound inhibitors of urea transporters
|
|
CA2676715A1
(en)
|
2007-02-12 |
2008-08-21 |
Merck & Co., Inc. |
Piperazine derivatives for treatment of ad and related conditions
|
|
WO2009008980A2
(en)
|
2007-07-05 |
2009-01-15 |
Schering Corporation |
Tetrahydropyranochromene gamma secretase inhibitors
|
|
US8618123B2
(en)
|
2007-07-17 |
2013-12-31 |
Merck Sharp & Dohme Corp. |
Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
|
|
US7935815B2
(en)
|
2007-08-31 |
2011-05-03 |
Eisai R&D Management Co., Ltd. |
Imidazoyl pyridine compounds and salts thereof
|
|
ES2529648T3
(es)
|
2007-08-31 |
2015-02-24 |
Eisai R&D Management Co., Ltd. |
Compuesto policíclico
|
|
TW200920362A
(en)
|
2007-09-11 |
2009-05-16 |
Daiichi Sankyo Co Ltd |
Alkylsulfone derivatives
|
|
US8084477B2
(en)
|
2007-10-31 |
2011-12-27 |
Bristol-Myers Squibb Company |
Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
|
|
US8093276B2
(en)
|
2007-10-31 |
2012-01-10 |
Bristol-Myers Squibb Company |
Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
|
|
EA018582B1
(ru)
|
2007-11-20 |
2013-09-30 |
Янссен Фармацевтика Н.В. |
Соединения циклоалкилокси- и гетероциклоалкилоксипиридина как модуляторы гистаминового рецептора н
|
|
KR101595238B1
(ko)
|
2007-12-21 |
2016-02-18 |
리간드 파마슈티칼스 인코포레이티드 |
선택적 안드로겐 수용체 조절제(ｓａｒｍ) 및 이의 용도
|
|
WO2009120783A1
(en)
*
|
2008-03-25 |
2009-10-01 |
The Johns Hopkins University |
High affinity inhibitors of hepatitis c virus ns3/4a protease
|
|
WO2009128057A2
(en)
|
2008-04-18 |
2009-10-22 |
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al |
Psycho-pharmaceuticals
|
|
CN102088855A
(zh)
*
|
2008-05-08 |
2011-06-08 |
百时美施贵宝公司 |
2-芳基甘氨酰胺衍生物
|
|
GB0812969D0
(en)
|
2008-07-15 |
2008-08-20 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
|
TW201020247A
(en)
*
|
2008-11-06 |
2010-06-01 |
Gruenenthal Gmbh |
Substituierte disulfonamide
|
|
US8044077B2
(en)
|
2009-03-19 |
2011-10-25 |
Bristol-Myers Squibb Company |
Alpha-(N-sulfonamido)acetamide compounds incorporating deuterium as inhibitors of beta amyloid peptide production
|
|
US7977362B2
(en)
|
2009-03-20 |
2011-07-12 |
Bristol-Myers Squibb Company |
Alpha-(N-benzenesulfonamido)cycloalkyl derivatives
|
|
US8252821B2
(en)
|
2009-04-14 |
2012-08-28 |
Bristol-Myers Squibb Company |
Bioavailable capsule compositions of amorphous alpha-(N-sulfonamido)acetamide compound
|
|
CN102459251B
(zh)
|
2009-05-14 |
2015-05-20 |
詹森药业有限公司 |
作为白三烯a4水解酶的调节剂的具有两个稠合双环杂芳基部分的化合物
|
|
EP2493497A4
(en)
|
2009-11-01 |
2013-07-24 |
Brigham & Womens Hospital |
NOTCH INHIBITION IN THE TREATMENT AND PROPHYLAXIS OF ADIPOSITAS AND METABOLISM SYNDROME
|
|
CN103193691B
(zh)
*
|
2012-01-06 |
2017-08-25 |
中国科学院上海药物研究所 |
磺胺类化合物、药物组合物及其制法和应用
|
|
CN104822267B
(zh)
*
|
2012-02-29 |
2018-01-23 |
巴鲁克·S·布伦博格研究所 |
乙型肝炎病毒共价闭合环状dna形成的抑制剂及其使用方法
|
|
WO2013192078A1
(en)
|
2012-06-22 |
2013-12-27 |
Temple University - Of The Commonwealth System Of Higher Education |
Synthetic pgpg analogs, methods of preparation and methods of use
|
|
CN104684899B
(zh)
*
|
2012-09-27 |
2017-07-04 |
霍夫曼-拉罗奇有限公司 |
取代的磺酰胺化合物
|
|
AU2014247953A1
(en)
|
2013-04-05 |
2015-11-12 |
Mitobridge, Inc. |
PPAR agonists
|
|
EP3094323A4
(en)
|
2014-01-17 |
2017-10-11 |
Ligand Pharmaceuticals Incorporated |
Methods and compositions for modulating hormone levels
|
|
EP2932966A1
(en)
|
2014-04-16 |
2015-10-21 |
Novartis AG |
Gamma secretase inhibitors for treating respiratory diseases
|
|
CN104151277A
(zh)
*
|
2014-06-30 |
2014-11-19 |
北京万全德众医药生物技术有限公司 |
盐酸决奈达隆一种氧化杂质的制备方法
|
|
WO2016057322A1
(en)
|
2014-10-08 |
2016-04-14 |
Salk Institute For Biological Studies |
Ppar agonists and methods of use thereof
|
|
CA2969756A1
(en)
*
|
2014-12-05 |
2016-06-09 |
Aquinnah Pharmaceuticals, Inc. |
Sulfonamide derivatives, compositions and methods of use in the treatment of neurodegenerative diseases
|
|
CN106466313A
(zh)
*
|
2015-08-18 |
2017-03-01 |
中国科学院上海药物研究所 |
一类磺酰胺基取代的酰胺类衍生物在制备用于治疗阿尔茨海默病的药物中的用途
|
|
KR102667386B1
(ko)
|
2015-10-07 |
2024-05-21 |
미토브리지, 인크. |
Ppar 효능제, 화합물, 제약 조성물, 및 그의 사용 방법
|
|
BR112018069930B1
(pt)
|
2016-04-13 |
2024-02-20 |
Mitobridge, Inc |
Compostos agonistas de ppar, uso dos mesmos e composição farmacêutica
|
|
TWI754702B
(zh)
*
|
2016-12-28 |
2022-02-11 |
德商Ｕｃｂ製藥有限公司 |
（氮雜）吲哚－和苯並呋喃－３－磺醯胺類
|
|
JP7395480B2
(ja)
|
2018-01-10 |
2023-12-11 |
クラ セラピューティクス， エルエルシー |
フェニルスルホンアミドを含む薬学的組成物、及びそれらの治療的適用
|
|
WO2020016377A1
(en)
|
2018-07-19 |
2020-01-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Combination for treating cancer
|
|
AU2020257397B2
(en)
|
2019-04-19 |
2026-02-26 |
Ligand Pharmaceuticals Inc. |
Crystalline forms and methods of producing crystalline forms of a compound
|
|
CA3146159A1
(en)
*
|
2019-07-11 |
2021-01-14 |
Cura Therapeutics, Llc |
Phenyl compounds and pharmaceutical compositions thereof, and their therapeutic applications
|
|
CN112457687B
(zh)
*
|
2019-09-06 |
2022-10-25 |
台湾永光化学工业股份有限公司 |
新颖反应性染料
|
|
WO2022101481A1
(en)
|
2020-11-16 |
2022-05-19 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and compositions for predicting and treating uveal melanoma
|